首页> 外国专利> MicroRNA (miRNA) as a Biomarker for the identification of familial and nonfamilial colorectal cancer

MicroRNA (miRNA) as a Biomarker for the identification of familial and nonfamilial colorectal cancer

机译:MicroRNA(miRNA)作为鉴定家族性和非家族性结直肠癌的生物标志物

摘要

Claim 1: a method for Diagnosing colorectal cancer (CRC) in a Human subject, which comprises the following steps: identify a subject suspected of Suffering from CRC; to obtain one or more biological samples of the subject, where biological samples selected from the gr Upo is a Tissue Sample, a stool SampleA cell homogenate and one or more Biological Fluids, including Blood, lymph, plasma, urine, cerebrospinal fluid, amniotic fluid, pus, and Tears; determine the patterns of expression of one or more types of microRNA (miRNA) in biological samples by The use of a microarray,Where one or more types of microRNA are regulated positively or negatively regulated in a Tissue sample from the subject suspected of Suffering from CRC; and compare the pattern of expression of Mirna in the Biological sample from the subject suspected of PADE EC a CRC with the pattern of expression of Mirna in a tissue of a normal subject,Where the normal subject is a Subject that does not have a Healthy crc.reivindicaciu00f3n 6: the method of claim 1 wherein the CRC covers the Lynch Syndrome, tumors with level of microsatellite instability (MSI) and sporadic tumors with microsatellite Stable (MSS).
机译:1。一种用于诊断人类受试者中的结肠直肠癌的方法,该方法包括以下步骤:识别怀疑患有CRC的受试者;以及获得受试者的一种或多种生物样品,其中选自gr Upo的生物样品是组织样品,粪便样品A细胞匀浆和一种或多种生物液,包括血液,淋巴液,血浆,尿液,脑脊液,羊水,脓液和眼泪;通过使用微阵列来确定生物样品中一种或多种类型的微RNA(miRNA)的表达模式,其中组织样品中一种或多种类型的微RNA受到正调控或负调控,而疑似患有CRC的受试者;并比较怀疑来自PADE EC a CRC的受试者的生物学样品中Mirna的表达模式与正常受试者组织中Mirna的表达模式,其中正常受试者是没有健康crc的受试者6.根据权利要求1所述的方法,其中,所述CRC涵盖林奇综合症,具有微卫星不稳定性水平(MSI)的肿瘤和具有微卫星稳定度(MSS)的偶发性肿瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号